Bain Capital Public Equity LP Acquires 30,818 Shares of Haleon plc (NYSE:HLN)

Bain Capital Public Equity LP boosted its stake in shares of Haleon plc (NYSE:HLN) by 20.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 185,282 shares of the company’s stock after acquiring an additional 30,818 shares during the quarter. Haleon accounts for 1.1% of Bain Capital Public Equity LP’s portfolio, making the stock its 27th largest position. Bain Capital Public Equity LP’s holdings in Haleon were worth $1,768,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of Haleon by 3.7% during the fourth quarter. FMR LLC now owns 108,827,814 shares of the company’s stock worth $1,038,217,000 after purchasing an additional 3,909,545 shares during the last quarter. Wellington Management Group LLP grew its position in shares of Haleon by 67.5% during the 4th quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company’s stock worth $146,232,000 after buying an additional 6,175,835 shares during the period. Douglas Lane & Associates LLC raised its position in shares of Haleon by 1.9% in the 4th quarter. Douglas Lane & Associates LLC now owns 8,624,149 shares of the company’s stock valued at $82,274,000 after acquiring an additional 161,865 shares during the period. Envestnet Asset Management Inc. boosted its stake in Haleon by 0.8% during the 4th quarter. Envestnet Asset Management Inc. now owns 7,630,307 shares of the company’s stock worth $72,793,000 after acquiring an additional 58,444 shares during the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in Haleon by 18.3% during the fourth quarter. JPMorgan Chase & Co. now owns 6,014,903 shares of the company’s stock valued at $57,382,000 after purchasing an additional 930,701 shares during the period. 6.67% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on HLN. HSBC reiterated a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of Haleon in a research note on Monday, March 3rd. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Hsbc Global Res lowered Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Finally, Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Six investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $10.95.

Haleon Price Performance

HLN stock opened at $10.68 on Friday. The stock has a 50-day moving average price of $10.16 and a two-hundred day moving average price of $9.81. Haleon plc has a 1 year low of $8.12 and a 1 year high of $10.85. The stock has a market cap of $48.19 billion, a PE ratio of 31.41, a price-to-earnings-growth ratio of 2.82 and a beta of 0.24. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Equities analysts forecast that Haleon plc will post 0.43 EPS for the current fiscal year.

Haleon Increases Dividend

The firm also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be issued a $0.1166 dividend. The ex-dividend date of this dividend is Friday, April 25th. This is an increase from Haleon’s previous — dividend of $0.05. This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio (DPR) is 58.97%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.